Dr. Morgan - ASH 2008 - CRD: A Phase 1 Dose Escalation Study to Determine the Maximum Tolerated Dose of Cyclophosphamide in Combination with Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma
Gareth Morgan, MD Section of Haemato-Oncology The Institute of Cancer Research London, United Kingdom Member, IMF Board of Scientific Advisors
To view the video full screen, click on the small
button next to the volume control in the
lower right hand corner.